Mendus AB (publ) - Asset Resilience Ratio

Latest as of December 2025: 10.29%

Mendus AB (publ) (IMMU) has an Asset Resilience Ratio of 10.29% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Mendus AB (publ) (IMMU) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr64.66 Million

≈ $6.96 Million USD Cash + Short-term Investments

Total Assets

Skr628.32 Million

≈ $67.62 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Mendus AB (publ)'s Asset Resilience Ratio has changed over time. See net assets of Mendus AB (publ) for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Mendus AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Mendus AB (publ).

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr64.66 Million	10.29%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr64.66 Million	10.29%

Asset Resilience Insights

Moderate Liquidity: Mendus AB (publ) has 10.29% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Mendus AB (publ) Industry Peers by Asset Resilience Ratio

Compare Mendus AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Mendus AB (publ) (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Mendus AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	10.29%	Skr64.66 Million ≈ $6.96 Million	Skr628.32 Million ≈ $67.62 Million	-4.34pp
2024-12-31	14.63%	Skr101.91 Million ≈ $10.97 Million	Skr696.36 Million ≈ $74.94 Million	-1.34pp
2023-12-31	15.98%	Skr120.78 Million ≈ $13.00 Million	Skr755.95 Million ≈ $81.35 Million	+9.23pp
2022-12-31	6.75%	Skr41.85 Million ≈ $4.50 Million	Skr620.39 Million ≈ $66.76 Million	-14.80pp
2021-12-31	21.54%	Skr155.31 Million ≈ $16.71 Million	Skr720.98 Million ≈ $77.59 Million	-1.47pp
2020-12-31	23.01%	Skr167.64 Million ≈ $18.04 Million	Skr728.66 Million ≈ $78.42 Million	+18.53pp
2019-12-31	4.47%	Skr13.59 Million ≈ $1.46 Million	Skr303.83 Million ≈ $32.70 Million	-94.27pp
2018-12-31	98.74%	Skr444.70 Million ≈ $47.86 Million	Skr450.37 Million ≈ $48.47 Million	+46.61pp
2017-12-31	52.13%	Skr128.32 Million ≈ $13.81 Million	Skr246.15 Million ≈ $26.49 Million	+44.29pp
2016-12-31	7.84%	Skr9.53 Million ≈ $1.03 Million	Skr121.57 Million ≈ $13.08 Million	+1.68pp
2015-12-31	6.15%	Skr9.49 Million ≈ $1.02 Million	Skr154.24 Million ≈ $16.60 Million	-43.72pp
2014-12-31	49.87%	Skr35.43 Million ≈ $3.81 Million	Skr71.03 Million ≈ $7.64 Million	--

pp = percentage points

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$33.83 Million

Skr314.38 Million SEK

Market Cap Rank

#23305 Global

#446 in Sweden

Share Price

Skr5.13

Change (1 day)

+4.91%

52-Week Range

Skr3.96 - Skr10.02

All Time High

Skr737.49